TGF-Β1, PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis: Correspondence.
作者信息
Sookaromee Pathum, Wiwanitkit Viroj
机构信息
Private Academic Consultant, Bangkok Thailand.
Hainan Medical University, China.
出版信息
Asian Pac J Cancer Prev. 2021 Dec 1;22(12):4067. doi: 10.31557/APJCP.2021.22.12.4067.
Abstract
摘要
相似文献
1
TGF-Β1, PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis: Correspondence.转化生长因子-β1、帕他汀样磷脂酶域蛋白3基因变异与肝纤维化风险：通信
Asian Pac J Cancer Prev. 2021 Dec 1;22(12):4067. doi: 10.31557/APJCP.2021.22.12.4067.
2
TGF-Β1 & PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis and HCC in Egyptian Patients with HCV-Related Liver Cirrhosis.TGF-β1 和 PNPLA3 基因变异与埃及丙型肝炎相关肝硬化患者肝纤维化和 HCC 的风险。
Asian Pac J Cancer Prev. 2021 Oct 1;22(10):3317-3326. doi: 10.31557/APJCP.2021.22.10.3317.
3
Plasma concentration of transforming growth factor-beta1 and hepatic fibrosis in dogs.犬转化生长因子-β1的血浆浓度与肝纤维化
Can J Vet Res. 2008 Oct;72(5):428-31.
4
Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.靶向转化生长因子-β1的RNA干扰对刀豆蛋白A诱导的小鼠免疫性肝纤维化的影响
Hepatobiliary Pancreat Dis Int. 2009 Jun;8(3):300-8.
5
Active immunization against transforming growth factor beta1 prevents hepatic fibrosis in a rat model of liver disease.针对转化生长因子β1的主动免疫可预防肝病大鼠模型中的肝纤维化。
Can J Physiol Pharmacol. 2017 Jun;95(6):743-749. doi: 10.1139/cjpp-2016-0669. Epub 2017 Mar 16.
6
Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.表观遗传调控的微小RNA-9-5p通过转化生长因子β受体1和转化生长因子β受体2抑制肝星状细胞的激活。
Cell Physiol Biochem. 2017;43(6):2242-2252. doi: 10.1159/000484303. Epub 2017 Oct 27.
7
PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis.PNPLA3过表达导致易纤维化蛋白减少。
Hum Mol Genet. 2016 Dec 1;25(23):5212-5222. doi: 10.1093/hmg/ddw341.
8
Effects of Chinese traditional compound, JinSanE, on expression of TGF-beta1 and TGF-beta1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo.中药复方金三莪对实验性肝纤维化大鼠体内转化生长因子β1（TGF-β1）及其Ⅱ型受体mRNA、Smad3和Smad7表达的影响
World J Gastroenterol. 2005 Apr 21;11(15):2269-76. doi: 10.3748/wjg.v11.i15.2269.
9
Transforming growth factor beta-1 upregulates glucose transporter 1 and glycolysis through canonical and noncanonical pathways in hepatic stellate cells.转化生长因子-β1 通过经典和非经典途径上调肝星状细胞中的葡萄糖转运蛋白 1 和糖酵解。
World J Gastroenterol. 2021 Oct 28;27(40):6908-6926. doi: 10.3748/wjg.v27.i40.6908.
10
Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.岩白菜素 D 通过阻断 TGF-β/Smad 和 YAP 信号通路抑制肝星状细胞激活和肝纤维化。
Phytomedicine. 2020 Nov;78:153294. doi: 10.1016/j.phymed.2020.153294. Epub 2020 Jul 28.
本文引用的文献
1
TGF-Β1 & PNPLA3 Genetic Variants and the Risk of Hepatic Fibrosis and HCC in Egyptian Patients with HCV-Related Liver Cirrhosis.TGF-β1 和 PNPLA3 基因变异与埃及丙型肝炎相关肝硬化患者肝纤维化和 HCC 的风险。
Asian Pac J Cancer Prev. 2021 Oct 1;22(10):3317-3326. doi: 10.31557/APJCP.2021.22.10.3317.
2
Significance of Hereditary Hemochromatosis Gene (HFE) Mutations in Chronic Hepatitis C and Hepatocellular Carcinoma Patients in Egypt: A Pilot Study.埃及慢性丙型肝炎和肝细胞癌患者遗传性血色素沉着症基因 (HFE) 突变的意义：一项初步研究。
Asian Pac J Cancer Prev. 2021 Sep 1;22(9):2837-2845. doi: 10.31557/APJCP.2021.22.9.2837.
3
Association between MICA rs2596542 Polymorphism with the Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Patients.MICA rs2596542 多态性与慢性丙型肝炎患者肝细胞癌风险的关联。
Pathol Oncol Res. 2020 Jul;26(3):1519-1525. doi: 10.1007/s12253-019-00738-6. Epub 2019 Aug 31.
Zotero 插件